IL17A and COVID-19: The decreased circulating levels of critical inflammatory proteins, such as IL-6, IL-8, IL-17A, and CC chemokine ligand 28, observed by Livanos et al. [40], further indicate that COVID-19-induced changes in the immune system could enhance the gut microbiome environment by reducing overall inflammation.